XML 19 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIT) - USD ($)
Total
Series B Preferred Stock
Series C Preferred Stock
Common Stock—Voting
Common Stock—Voting
Series C Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series B Preferred Stock
Additional Paid-in Capital
Series C Preferred Stock
Accumulated Deficit
BALANCES at Dec. 31, 2012 $ (101,803,622)     $ 10,413   $ 24,017,444     $ (125,831,479)
Shares, Outstanding at Dec. 31, 2012       10,413,467          
Issuance of 7,952 shares of common stock for cash 49,891     $ 8   49,883      
Issuance of 7,952 shares of common stock for cash, shares       7,952          
Share-based compensation expense 978,352         978,352      
Preferred Stock dividend accretion   $ (4,215,230) $ (4,380,274)       $ (4,215,230) $ (4,380,274)  
Net loss (21,687,155)               (21,687,155)
BALANCES at Dec. 31, 2013 (131,058,038)     $ 10,421   16,450,175     (147,518,634)
Shares, Outstanding at Dec. 31, 2013       10,421,419          
Share-based compensation expense 1,553,985         1,553,985      
Issuance of common stock to consultant for services 9,991     $ 1   9,990      
Issuance of common stock to consultant for services, shares       666          
Preferred Stock dividend accretion   $ (4,271,550) (7,014,643)       $ (4,271,550) (7,014,643)  
Additional loss upon conversion of Series C Preferred Stock into common stock     (82,654,683)         (82,654,683)  
Shares issued upon consummation of Initial Public Offering (IPO) 164,405,679     $ 11,979   164,393,700      
Shares issued upon consummation of Initial Public Offering (IPO), shares       11,979,167          
Conversion of Preferred Series C into common stock upon consummation of IPO     $ 199,760,975   $ 11,067     $ 199,749,908  
Conversion of Preferred Series C into common stock upon consummation of IPO, shares         11,067,090        
Net loss (37,339,017)               (37,339,017)
BALANCES at Dec. 31, 2014 103,392,699     $ 33,468   288,216,882     (184,857,651)
Shares, Outstanding at Dec. 31, 2014       33,468,342          
Exercise of options to purchase common stock 291,749     $ 44   291,705      
Exercise of options to purchase common stock, shares       44,432          
Issuance of restricted stock units       $ 24   (24)      
Issuance of restricted stock units, shares       24,166          
Share-based compensation expense 3,976,423         3,976,423      
Net loss (3,710,812)               (3,710,812)
BALANCES at Dec. 31, 2015 $ 103,950,060     $ 33,537   $ 292,484,986     $ (188,568,463)
Shares, Outstanding at Dec. 31, 2015       33,536,940